Over the past few years, GLP-1 drugs have transformed the treatment landscape for obesity and type 2 diabetes. By mimicking a hormone that helps regulate blood sugar, slows digestion and curbs ...
RuneScape: Dragonwilds launches on PlayStation 5 later in 2026, developer Jagex has announced, marking the first time the RuneScape IP has made the jump from PC to consoles in its 25-year history. As ...
Jagex's annual summer roadmap update for Old School Runescape has arrived, and the rest of the year ahead is looking incredibly exciting. While the sheen of Leagues 6 has lost its luster, that's only ...
On March 3, 2026, the full “Worm Moon” will slip into Earth’s shadow and turn a copper-red for 58 minutes. This total lunar eclipse — often dubbed a “blood moon” — will be the last total lunar eclipse ...
Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. The phases of a total lunar ...
A rare celestial phenomena will occur during the next full moon of 2026 when the March worm moon turns into a dramatic fiery red blood moon amid a total lunar eclipse. The March full moon is known as ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min University of Cincinnati and UC ...
Suchandrima Bhowmik has written over 300 articles on various health conditions, medical news, and recent breakthroughs. Her work appears in several publications, including Medical News Today, ...
AstraZeneca has hailed another phase 3 win for its blood pressure drug candidate baxdrostat, boosting its attempts to turn the molecule’s long half-life into a competitive advantage. Baxdrostat, an ...
WASHINGTON — Quantum Space is acquiring propulsion technologies and facilities from Phase Four to support development of its Ranger maneuverable spacecraft. The company announced Sept. 22 it acquired ...
WILMINGTON, Del.--(BUSINESS WIRE)--Positive full results from the BaxHTN Phase III trial showed baxdrostat demonstrated a statistically significant and clinically meaningful reduction in mean seated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results